CCR

September 22, 2020

Black patients with knee osteoarthritis have worse outcomes than their white counterparts, shows a new study.

September 22, 2020

Cognitive impairment can be an ongoing issue for patients with rheumatic disease, such as lupus. A proper diagnosis includes a battery of tests, says Noa Shwartz, M.D., a physician-researcher with Albert Einstein College of Medicine in New York.

September 21, 2020

Simultaneous use of more than one drug is gaining traction as a treatment strategy for severe lupus symptoms, particularly in people with chronic kidney disease.

September 11, 2020

Report shows that sarilumab may be better at controlling severe and refractory pain in rheumatoid arthritis patients than adalimumab.

September 11, 2020

The investigational JAK inhibitor filgotinib―which is under study as a treatment for a number of rheumatic diseases―has been shown to be safe and well tolerated in psoriatic arthritis patients.

June 05, 2015

(CCR 2015) A number of new osteoporosis treatments are on the near horizon, drawing on a new understanding of bone biology, as described by a speaker at the Clinical Congress of Rheumatology.

June 03, 2015

(CCR2015) Nearly 100 new molecules are in development as RA treatments. This summary of a recent presentation by the ever-eloquent Ed Keystone MD gives a brief rundown of their mechanisms, progress, and potential.

May 29, 2015

The "Green Berets" of the brain, microglia cells, become hyperactive in fibromyalgia and are key to causing symptoms, said a psychologist and neuroscientist. Finding ways to control them is the key to future treatments, he feels.

May 27, 2015

(CCR 2015) A new rheumatoid arthritis (RA) research center in the UK intends to revolutionize the understanding and treatment of the rheumatoid arthritis by 2020 by using systems biology to move beyond the one-molecule paradigm.